← FDA Drug Approvals (Drugs@FDA)

ABILIFY

NDA · New Drug Application · Sponsor: OTSUKA · Approved 2006-09-20

Drug application

FDA Application #

NDA021866

Application type

New Drug Application

Brand name

ABILIFY

Generic name

Aripiprazole

Active ingredients

ARIPIPRAZOLE

Dosage form

INJECTABLE

Route

INTRAMUSCULAR

Marketing status

Discontinued

Sponsor

OTSUKA

First approval

2006-09-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown